The DOI matches its Crossref record.
Mac-2, a novel 32,000 Mr mouse macrophage subpopulation-specific antigen defined by monoclonal antibodies.
Abstract
Two monoclonal antibodies, M3/31 and M3/38, were obtained by fusion of mouse myeloma cells with rat spleen cells immunized to immunoadsorbent-purified macrophage glycoproteins. Co-precipitation experiments show that antigenic determinants recognized by these two antibodies reside on the same molecular species, termed Mac-2, Mac-2, an antigen of 32,000 Mr, is synthesized by and expressed on the surface of thioglycollate-elicited macrophages as shown by [35S]-methionine and 125I labeling. Saturation binding experiments show that thioglycollate-elicited macrophages express 1.7 X 10(5) Mac-2 sites/cell. Thioglycollate-elicited macrophages are strongly absorptive for 125I-labeled M3/38 MAb. Kidneys are also absorptive; however, evidence is presented pointing to the nonspecificity of this absorption. Lymph node and thymus are negative, whereas spleen and bone marrow are weakly absorptive, probably due to stromal cells. Nonlymphoid tissues, such as lung, liver, heart, and brain, exhibit slight or no absorbing capacity. Cell suspensions from spleen, bone marrow, thymus, and peripheral lymph node are greater than 99% Mac-2- by immunofluorescent flow cytometry. In contrast, thioglycollate-elicited macrophages are greater than 96% strongly positive for Mac-2. Only 20% of peptone-elicited cells are weakly positive, whereas resident peritoneal macrophages and other macrophage elicited by Listeria monocytogenes, Con A, or LPS are greater than 98% negative. SDS-PAGE of [35S]-methionine-labeled Mac-2 shows that thioglycollate-elicited macrophages synthesize 10- to 30-fold more Mac-2 than other peritoneal macrophage subpopulations, whereas all types of peritoneal macrophages synthesize and express on their surfaces similar amounts of the Mac-1 antigen. Mac-2 antigen is therefore induced in macrophages only in response to specific differentiative signals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
IgE and mast cells in allergic disease
Galli, S. J., & Tsai, M. (2012) · Nature Medicine · doi:10.1038/nm.2755 · Cited by 1,799
c-Fos: a Key Regulator of Osteoclast-Macrophage Lineage Determination and Bone Remodeling
Grigoriadis, A. E., Wang, Z.-Q., Cecchini, M. G., Hofstetter, W., Felix, R., Fleisch, H. A., & Wagner, E. F. (1994) · Science · doi:10.1126/science.7939685 · Cited by 1,260
Galectin-3: An open-ended story
Dumic, J., Dabelic, S., & Flögel, M. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2005.12.020 · Cited by 1,169
Role of advanced glycation end products in cellular signaling
Ott, C., Jacobs, K., Haucke, E., Navarrete Santos, A., Grune, T., & Simm, A. (2014) · Redox Biology · doi:10.1016/j.redox.2013.12.016 · Cited by 1,150
Anti-Mac-1 selectively inhibits the mouse and human type three complement receptor.
Beller, D. I., Springer, T. A., & Schreiber, R. D. (1982) · The Journal of experimental medicine · doi:10.1084/jem.156.4.1000 · Cited by 606
Self-citationLymphatic vascular defects promoted by Prox1 haploinsufficiency cause adult-onset obesity
Harvey, N. L., Srinivasan, R. S., Dillard, M. E., Johnson, N. C., Witte, M. H., Boyd, K., Sleeman, M. W., & Oliver, G. (2005) · Nature Genetics · doi:10.1038/ng1642 · Cited by 580
Galectin-3 Expression and Secretion Links Macrophages to the Promotion of Renal Fibrosis
Henderson, N. C., Mackinnon, A. C., Farnworth, S. L., Kipari, T., Haslett, C., Iredale, J. P., Liu, F.-T., Hughes, J., & Sethi, T. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070726 · Cited by 562
Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL.
Kelliher, M. A., McLaughlin, J., Witte, O. N., & Rosenberg, N. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6649 · Cited by 514
Wallerian degeneration: the innate-immune response to traumatic nerve injury
Rotshenker, S. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-109 · Cited by 510
Boyd, R. L., Tucek, C. L., Godfrey, D. I., Izon, D. J., Wilson, T. J., Davidson, N. J., Bean, A. G. D., Ladyman, H. M., Ritter, M. A., & Hugo, P. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90248-j · Cited by 450
Vlassara, H., Li, Y. M., Imani, F., Wojciechowicz, D., Yang, Z., Liu, F.-T., & Cerami, A. (1995) · Molecular Medicine · doi:10.1007/bf03401604 · Cited by 421
Identification of galectin-3 as a factor in pre-mRNA splicing.
Dagher, S. F., Wang, J. L., & Patterson, R. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.4.1213 · Cited by 397
Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z
Sciacchitano, S., Lavra, L., Morgante, A., Ulivieri, A., Magi, F., De Francesco, G., Bellotti, C., Salehi, L., & Ricci, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020379 · Cited by 377
Galectin-3 – A jack-of-all-trades in cancer
Newlaczyl, A. U., & Yu, L.-G. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.09.003 · Cited by 362
Markers of mouse macrophage development detected by monoclonal antibodies
Leenen, P. J. M., de Bruijn, M. F. T. R., Voerman, J. S. A., Campbell, P. A., & van Ewijk, W. (1994) · Journal of Immunological Methods · doi:10.1016/0022-1759(94)90005-1 · Cited by 333
Kipps, T. J. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60663-x · Cited by 321
Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update
Suthahar, N., Meijers, W. C., Silljé, H. H. W., Ho, J. E., Liu, F.-T., & de Boer, R. A. (2018) · Theranostics · doi:10.7150/thno.22196 · Cited by 309
Matsumoto, R., Matsumoto, H., Seki, M., Hata, M., Asano, Y., Kanegasaki, S., Stevens, R. L., & Hirashima, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.27.16976 · Cited by 302
Kopitz, J., von Reitzenstein, C., André, S., Kaltner, H., Uhl, J., Ehemann, V., Cantz, M., & Gabius, H.-J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105135200 · Cited by 281
L-29, an endogenous lectin, binds to glycoconjugate ligands with positive cooperativity
Massa, S. M., Cooper, D. N. W., Leffler, H., & Barondes, S. H. (1993) · Biochemistry · doi:10.1021/bi00052a033 · Cited by 262
Woo, H. J., Shaw, L. M., Messier, J. M., & Mercurio, A. M. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39081-7 · Cited by 258
Argüeso, P., Guzman-Aranguez, A., Mantelli, F., Cao, Z., Ricciuto, J., & Panjwani, N. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.033332 · Cited by 257
Türeci, Ö., Schmitt, H., Fadle, N., Pfreundschuh, M., & Sahin, U. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.10.6416 · Cited by 255
Luo, T., Nocon, A., Fry, J., Sherban, A., Rui, X., Jiang, B., Xu, X. J., Han, J., Yan, Y., Yang, Q., et al. (2016) · Diabetes · doi:10.2337/db15-1122 · Cited by 172
“The crown-like structure positively stained by MAC-2, a lectin that is expressed by activated macrophages (40), was dramatically increased in ob/ob mice (Supplementary Fig.”
BackgroundThe therapeutic potential of galectin-3 inhibition in fibrotic disease
Slack, R. J., Mills, R., & Mackinnon, A. C. (2021) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2020.105881 · Cited by 136
Rotshenker, S. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9186-7 · Cited by 111
Nomura, K., Vilalta, A., Allendorf, D. H., Hornik, T. C., & Brown, G. C. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1502532 · Cited by 111
Yoshida, H., Watanabe, H., Ishida, A., Watanabe, W., Narumi, K., Atsumi, T., Sugita, C., & Kurokawa, M. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.10.038 · Cited by 66
Uchino, Y., Woodward, A. M., Mauris, J., Peterson, K., Verma, P., Nilsson, U. J., Rajaiya, J., & Argüeso, P. (2018) · Immunology · doi:10.1111/imm.12899 · Cited by 31
Metadata
- Authors
- Ho, M. K., & Springer, T. A.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1982-03-01
- Volume
- 128
- Issue
- 3
- Pages
- 1221-1228
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1945626132
- Cited by
- 426
- References
- 0
- FWCI
- 4.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.